{{Rsnum
|rsid=13390159
|Gene=ASB18
|Chromosome=2
|position=236247906
|Orientation=plus
|GMAF=0.2254
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ASB18
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 4.4 | 27.4 | 68.1
| HCB | 0.0 | 12.5 | 87.5
| JPT | 0.0 | 2.7 | 97.3
| YRI | 40.4 | 47.3 | 12.3
| ASW | 22.8 | 50.9 | 26.3
| CHB | 0.0 | 12.5 | 87.5
| CHD | 0.0 | 8.3 | 91.7
| GIH | 4.0 | 25.7 | 70.3
| LWK | 30.0 | 51.8 | 18.2
| MEX | 3.4 | 19.0 | 77.6
| MKK | 20.5 | 47.4 | 32.1
| TSI | 3.0 | 24.8 | 72.3
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20339536
|Trait=Response to statin therapy
|Title=Genome-wide association of lipid-lowering response to statins in combined study populations
|RiskAllele=A
|Pval=2E-7
|OR=None
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}